Historical record - last NADAC publication: 7/16/2015
Product Information
NEUPOGEN 300 MCG/0.5 ML SYR is a brand product labeled by Amgen Inc., priced at $632.3279 per ML under NDC 55513092410. Its NADAC has been published 137 times since Nov 28, 2013.
Strength
300 ug/.5mL
Manufacturer
Amgen Inc.NDC
55513092410
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
7/16/2015
Active Ingredients
FILGRASTIMApproval Type
Biologic (BLA)
FDA Application
BLA103353On Market Since
10/2/2000
Pharmacological Classes
Price Statistics
The NADAC for NEUPOGEN 300 MCG/0.5 ML SYR has been published 137 times since Nov 28, 2013, and over the history we have for it it has risen 4.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $632.3279 per ML |
|---|---|
| All-time high | $632.3279 (Jul 13, 2016) |
| All-time low | $604.7416 (Nov 28, 2013) |
| Median price | $622.9708 |
| Average price | $619.6024 |
| Largest weekly change | +2.0% (Jan 28, 2015) |
| Weeks tracked | 137 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NEUPOGEN 300 MCG/0.5 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for NEUPOGEN 300 MCG/0.5 ML SYR, manufactured by Amgen Inc., is $632.3279 per ML (NDC 55513092410), effective Jul 13, 2016.
How has the price of NEUPOGEN 300 MCG/0.5 ML SYR changed over time?
Over the history we have for it, the NADAC for NEUPOGEN 300 MCG/0.5 ML SYR has risen 4.6%. It has been tracked across 137 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEUPOGEN 300 MCG/0.5 ML SYR?
Since Nov 28, 2013, the NADAC for NEUPOGEN 300 MCG/0.5 ML SYR has ranged from a low of $604.7416 (Nov 28, 2013) to a high of $632.3279 (Jul 13, 2016), with a median of $622.9708 per ML.
Are there cheaper alternatives to NEUPOGEN 300 MCG/0.5 ML SYR?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, NEUPOGEN 300 MCG/ML VIAL, is $304.3070 per ML — about 52% below NEUPOGEN 300 MCG/0.5 ML SYR.
Who manufactures NEUPOGEN 300 MCG/0.5 ML SYR?
NEUPOGEN 300 MCG/0.5 ML SYR (NDC 55513092410) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification